Anti-Nogo-A Antibody Therapy Improves Functional Outcome Following Traumatic Brain Injury.
Brian E Powers, Son T Ton, Robert G Farrer and 4 others
PMID 37837331WHAT IT FOUND
Rats given anti-Nogo-A antibody after brain injury recovered skilled reaching and walking better than controls.
Recovery appeared at six weeks, linked to new nerve connections crossing the brain midline. This is animal data only; no human evidence exists.
Key findings
01Anti-Nogo-A treated rats showed significantly better success scores in a skilled reaching task at weeks 6, 7, and 8 post-injury compared to control groups.
02Treated rats made significantly fewer foot slips on a horizontal ladder walk task with the impaired forelimb at 56 days post-injury.
03Histological analysis showed increased midline-crossing nerve fibers to the red nucleus in treated rats, suggesting enhanced neuroplasticity.
STILL TO COME
How it was doneWhat they found
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study was conducted entirely in male rats; results may not apply to females or humans. The sample size was small, with only 23 rats analyzed after exclusions. The treatment involved surgical implantation of pumps into the brain ventricles, which is highly invasive and not currently a standard clinical approach. Functional improvements were not observed until six weeks post-injury, suggesting a delayed effect that requires long-term follow-up to confirm. The study did not include a rehabilitation component beyond the testing itself, limiting comparisons to clinical practice where therapy is standard.
Declared interests
The research was supported by the U.S. Department of Veterans Affairs and the National Institutes of Health. No commercial conflicts of interest are declared in the provided text.
The easy way to misread this
Do not interpret this as evidence that anti-Nogo-A therapy is available or effective for human patients. The treatment required invasive brain surgery in rats, and human trials for this specific application in TBI are not reported here.